Quarterly report pursuant to Section 13 or 15(d)

Related Party Matters (Detail Textuals)

v3.10.0.1
Related Party Matters (Detail Textuals) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 06, 2018
Feb. 28, 2018
Jan. 19, 2018
Dec. 28, 2017
Apr. 01, 2017
Jun. 30, 2014
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Related Party Transaction [Line Items]                      
Maximum aggregate gross proceeds             $ 900,000   $ 900,000    
Proceeds from convertible debt issuance                 400,000    
Convertible debt                     $ 235,000
Loss on extinguishment of debt                 (590,392)    
Amortization of convertible debt discount                 34,608    
Change in fair value of conversion rights of convertible debt                 185,000    
Accrued interest related to the convertible debt             3,767   3,767    
Independent contractor agreement | K2C, Inc.                      
Related Party Transaction [Line Items]                      
Monthly fee         $ 20,000 $ 10,000          
Total expense incurred under agreement               $ 60,000 220,000 $ 150,000  
Independent contractor agreement | Emerald Health Sciences Inc                      
Related Party Transaction [Line Items]                      
Total expense incurred under agreement             150,000   $ 400,000    
Initial term of agreement   10 years                  
Percentage of accrued interest on outstanding balance                 12.00%    
Separation and release agreement | K2C, Inc.                      
Related Party Transaction [Line Items]                      
Lump sum payment in agreement   $ 180,000                  
Recognized additional stock based compensation expense of restricted stock and option awards   $ 112,270                  
Separation and release agreement | K2C, Inc. | Immediate vesting                      
Related Party Transaction [Line Items]                      
Number of restricted common stock vested   900,000                  
Separation and release agreement | K2C, Inc. | October 20, 2015                      
Related Party Transaction [Line Items]                      
Number of restricted common stock vested   325,000                  
Separation and release agreement | K2C, Inc. | November 21, 2014                      
Related Party Transaction [Line Items]                      
Number of restricted common stock vested   125,000                  
Consulting Agreement | Emerald Health Sciences Inc                      
Related Party Transaction [Line Items]                      
Total expense incurred under agreement             15,000   $ 45,000    
Initial term of agreement 1 year                    
Accrued and accounts payable - related party             15,000   15,000    
Annual fee $ 60,000                    
Period of discretionary annual bonus payable to contractor after each fiscal year end 120 days                    
Secured promissory note and security agreement | Emerald Health Sciences Inc | Bridge Loan                      
Related Party Transaction [Line Items]                      
Maximum aggregate gross proceeds       $ 900,000              
Proceeds from convertible debt issuance     $ 500,000 500,000              
Funds received under the Secured Promissory Note     400,000 400,000              
Convertible debt       $ 265,000              
Increase in conversion liability     $ 360,000                
Initial conversion price     $ 0.10                
Number of common shares issued in conversion of bridge loan     9,000,000                
Loss on extinguishment of debt                 590,392    
Amortization of convertible debt discount                 34,608    
Marked to market the conversion liabilities             $ 810,000   810,000    
Change in fair value of conversion rights of convertible debt                 $ 185,000